|
Characteristic
|
Training Set (n = 171)
|
Validation Set (n = 171)
|
P value*
|
ICGC HCC dataset (n = 212)
|
GSE15654 dataset (n = 216)
|
|---|
|
Age (years)
|
≤60
|
81
|
84
|
0.828
|
43
|
–
|
|
> 60
|
90
|
87
|
169
|
–
|
|
Survival Status
|
Living
|
109
|
110
|
1
|
176
|
150
|
|
Dead
|
62
|
61
|
36
|
66
|
|
Sex
|
Female
|
55
|
54
|
1
|
50
|
–
|
|
Male
|
116
|
117
|
162
|
–
|
|
Grade
|
G1
|
24
|
29
|
0.513
|
–
|
–
|
|
G2
|
82
|
79
|
–
|
–
|
|
G3
|
59
|
52
|
–
|
–
|
|
G4
|
4
|
8
|
–
|
–
|
|
Pathologic T stage
|
T1
|
79
|
89
|
0.028
|
–
|
–
|
|
T2
|
54
|
30
|
–
|
–
|
|
T3
|
43
|
41
|
–
|
–
|
|
T4
|
4
|
9
|
–
|
–
|
|
Pathologic N stage
|
N0
|
120
|
119
|
0.934
|
–
|
–
|
|
N1/Nx
|
50
|
52
|
–
|
–
|
|
Pathologic M stage
|
M0
|
128
|
116
|
0.188
|
–
|
–
|
|
M1/Mx
|
43
|
55
|
–
|
–
|
|
Tumor Stage
|
Stage I
|
78
|
83
|
0.011
|
33
|
–
|
|
Stage II
|
50
|
27
|
102
|
–
|
|
Stage III
|
34
|
46
|
61
|
–
|
|
Stage IV
|
1
|
2
|
16
|
–
|
- *Chi-Squared test. ICGC, International Cancer Genome Consortium
